MLICM
ARVN icon

Metropolitan Life Insurance Company (MetLife)’s Arvinas ARVN Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,636
Closed -$109K – 178
2024
Q1 		$109K Sell
2,636
-166
-6% -$7.25K ﹤0.01% 1005
2023
Q4 		$115K Sell
2,802
-253
-8% -$5.91K 0.01% 1002
2023
Q3 		$60K Buy
3,055
+291
+11% +$7.14K ﹤0.01% 1299
2023
Q2 		$68.6K Hold
2,764
– – ﹤0.01% 1234
2023
Q1 		$75.5K Sell
2,764
-208
-7% -$6.57K ﹤0.01% 1159
2022
Q4 		$102K Hold
2,972
– – ﹤0.01% 1046
2022
Q3 		$132K Hold
2,972
– – 0.01% 868
2022
Q2 		$125K Hold
2,972
– – 0.01% 933
2022
Q1 		$200K Sell
2,972
-9,111
-75% -$621K 0.01% 818
2021
Q4 		$992K Buy
12,083
+607
+5% +$49.4K 0.01% 969
2021
Q3 		$943K Sell
11,476
-530
-4% -$46.8K 0.01% 1005
2021
Q2 		$924K Buy
12,006
+2,328
+24% +$162K 0.01% 1074
2021
Q1 		$640K Hold
9,678
– – 0.01% 1264
2020
Q4 		$822K Buy
9,678
+504
+5% +$17.4K 0.01% 1022
2020
Q3 		$217K Hold
9,174
– – ﹤0.01% 1721
2020
Q2 		$308K Buy
9,174
+2,818
+44% +$120K 0.01% 1529
2020
Q1 		$256K Hold
6,356
– – 0.01% 1447
2019
Q4 		$261K Hold
6,356
– – ﹤0.01% 1738
2019
Q3 		$137K Buy
6,356
+4,970
+359% +$122K ﹤0.01% 2129
2019
Q2 		$30.5K Buy
+1,386
New +$29.1K ﹤0.01% 2552

Other funds holding ARVN

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ARVN Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Arvinas (ARVN) in Q2 2024, closing a stake of 2,636 shares — an estimated $109K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ARVN in Q2 2019 and held it in 20 quarters. The position peaked at $992K in Q4 2021. 207 funds tracked by Wall St. Rank hold ARVN as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Arvinas position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,636 Arvinas shares in Q2 2024, an estimated $109K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Arvinas in Q2 2019 and held it in 20 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Arvinas position peaked at $992K in Q4 2021.
  • 207 funds tracked by Wall St. Rank held Arvinas as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.